A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine
Clinical trial NCT06147895 · COMPLETED
Trial details
- NCT number
- NCT06147895
- Sponsor
- Aribio Lab Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-17
- Primary completion
- 2023-09-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.